Opal Therapeutics

Opal Therapeutics is a femtech company in San Francisco, United States, founded in 2024. It has raised $275K across 1 round, most recently a $275K Grant in September 2024.

Catalyzing drug discovery for women's health in endometriosis and fibroids

Employees
1–10
Founded
2024
Business Model
B2B
Total Funding
$275K
Last Round
$275K GrantSep 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Opal Therapeutics is a women's health biotech company building high-fidelity, patient-derived uterine organoid models of endometriosis and fibroids. Their platform helps biotech and pharma companies accelerate drug discovery and de-risk development through compound screening and biomarker validation using human preclinical data.

Summary

It lists 1–10 employees. It has raised $275K in total across 1 round, most recently a $275K Grant round in Sep 2024. Investors include National Science Foundation.

Funding History

Data from Indexed.vcUpdated
GrantSep 2024
$275K

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Opal Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/opal-therapeutics"><img src="https://indexed.vc/api/badge/company/opal-therapeutics" alt="Opal Therapeutics on Indexed.vc" width="260" height="76" /></a>